Trial Profile
An Open Label Study to Evaluate the Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Headache Attributed to Mild Traumatic Injury to the Head
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Erenumab (Primary)
- Indications Post-traumatic headache
- Focus Therapeutic Use
- Acronyms STOP
- 07 Feb 2020 Status changed from recruiting to completed.
- 07 Jun 2019 New trial record